Astek Diagnostics
Astek Diagnostics is a precision diagnostics company focused on revolutionizing the detection and treatment of bacterial infections. Their flagship product, the JIDDU system, offers rapid and accurate diagnostics for urinary tract infections (UTIs) and antibiotic sensitivity within one hour. This innovation aims to improve patient outcomes by reducing complications, healthcare costs, and antimicrobial resistance. Astek is committed to expanding its diagnostic capabilities to include multiple sample types, including urine, cerebrospinal fluid (CSF), effluent, and blood, with a market launch planned for 2025.
Astek Diagnostics
What We Do
An innovative clinical diagnostics platform that offers infection confirmation for urinary tract infections (UTIs) and antibiotic sensitivity indication within 1 hour. It aims to improve diagnostic speed and accuracy, reducing patient complications and healthcare costs.
Application Area
Regenerative Medicine
Digital Health Technologies
Show More (3)Key People
News & Updates
Astek Diagnostics was selected to participate in the 2024 MedTech Innovator cohort, the world's largest accelerator for medical devices, digital health, and diagnostics.
Astek Diagnostics aims to launch a point-of-care infection test system by late 2025 to determine within an hour whether a patient has a urinary tract infection and which antibiotics are effective.
Astek Diagnostics announced a strategic partnership with MedStar Health Research Institute to advance innovation in UTI infection identification and antibiotic sensitivity detection through the Jiddu Analyzer.
Astek Diagnostics partnered with MRR Children’s Hospital in India to address acute bacterial meningitis treatment challenges using the Jiddu Analyzer.
Patent No. 11,788,962, licensed from the University of Maryland, covers the technology used in Astek's testing system for detecting bacterial contamination.